New Food Invest
-
DATABASE (1659)
-
ARTICLES (741)
With a special interest in enterprise tech, Silicon Valley-based Omega Venture Partners has 25 startups in its portfolio and, to date, has invested from pre-seed to Series E stages. It has managed eight exits to date. Its most recent investments were in the 2020 $55m Series B round of US-based small business management platform ZenBusiness and in the February 2021 $50m Series B round of US voice transcription software Otter.ai. The investor boasts an extensive network of major corporations as advisors and partners including Google, Microsoft, Amazon, IBM, SAP and CitiGroup.
With a special interest in enterprise tech, Silicon Valley-based Omega Venture Partners has 25 startups in its portfolio and, to date, has invested from pre-seed to Series E stages. It has managed eight exits to date. Its most recent investments were in the 2020 $55m Series B round of US-based small business management platform ZenBusiness and in the February 2021 $50m Series B round of US voice transcription software Otter.ai. The investor boasts an extensive network of major corporations as advisors and partners including Google, Microsoft, Amazon, IBM, SAP and CitiGroup.
Founded in Connecticut in 2014, Oak has a total of $3.3bn assets under management, the overwhelming majority within healthcare and fintech, and invests at all stages of growth. Approximately one third of its portfolio companies that currently number 55, seek re-investment from the VC. It has managed eight exits to date and has a special interest in investing in women in tech.Its most recent investments have included in Canadian unicorn the startup financing fintech Clearco that raised $100m in its April 2021 Series C round, and, the same month, in US virtual healthcare platform Firefly Health’s $40m Series B round.
Founded in Connecticut in 2014, Oak has a total of $3.3bn assets under management, the overwhelming majority within healthcare and fintech, and invests at all stages of growth. Approximately one third of its portfolio companies that currently number 55, seek re-investment from the VC. It has managed eight exits to date and has a special interest in investing in women in tech.Its most recent investments have included in Canadian unicorn the startup financing fintech Clearco that raised $100m in its April 2021 Series C round, and, the same month, in US virtual healthcare platform Firefly Health’s $40m Series B round.
DCVC (formerly Data Collective)
San Francisco-based DCVC, formerly named Data Collective, has made more than 400 investments in its 20 year history, with deep tech and science in general its key investment interests. It currently has 148 companies in its portfilio and has managed 48 exits to date, including acquisitions by Twitter and Amazon. Its most recent investments have included in the April 2021 £60m Series A round of British antibody medtech Alchemab Therapeutics and in the March 2021 $75m Series B round of Israeli blockchain development tool StarkWare Industries.
San Francisco-based DCVC, formerly named Data Collective, has made more than 400 investments in its 20 year history, with deep tech and science in general its key investment interests. It currently has 148 companies in its portfilio and has managed 48 exits to date, including acquisitions by Twitter and Amazon. Its most recent investments have included in the April 2021 £60m Series A round of British antibody medtech Alchemab Therapeutics and in the March 2021 $75m Series B round of Israeli blockchain development tool StarkWare Industries.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms.
BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies. His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.
Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies. His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.
Jörg Mohaupt is the head of media at Warner Music Group and an angel investor who has funded several startups to date, many in the area of music. His other most recently known investments were in the August 2019 £2.2m seed round of British fintech for adolescents Penfold and in the May 2019 $1.7m seed round of Swedish music sampling store Tracklib.
Jörg Mohaupt is the head of media at Warner Music Group and an angel investor who has funded several startups to date, many in the area of music. His other most recently known investments were in the August 2019 £2.2m seed round of British fintech for adolescents Penfold and in the May 2019 $1.7m seed round of Swedish music sampling store Tracklib.
Boyu Capital is a China-focused investment firm with offices in Beijing and Hong Kong. It manages tens of billions of US dollars and is one of the largest private equity investment firm in China, and mainly invests in sectors of consumer and retail, financial services, healthcare, media and technology.Boyu Capital was founded in 2011 by the late Ma Xuezheng (died in September 2019), former senior vice-president and financial director of Lenovo Group and managing director and partner of TPG, and Zhang Zixin (Louis Cheung), former general manager of Ping An Insurance. Boyu Capital's first chairman of the board was Jiang Zhicheng (Alvin Jiang), the grandson of former Chinese president Jiang Zemin.
Boyu Capital is a China-focused investment firm with offices in Beijing and Hong Kong. It manages tens of billions of US dollars and is one of the largest private equity investment firm in China, and mainly invests in sectors of consumer and retail, financial services, healthcare, media and technology.Boyu Capital was founded in 2011 by the late Ma Xuezheng (died in September 2019), former senior vice-president and financial director of Lenovo Group and managing director and partner of TPG, and Zhang Zixin (Louis Cheung), former general manager of Ping An Insurance. Boyu Capital's first chairman of the board was Jiang Zhicheng (Alvin Jiang), the grandson of former Chinese president Jiang Zemin.
Founded in 2017, Starlight Ventures is a venture capital firm based in Miami, Florida. Investing mainly in US-based startups, the VC currently has 29 startups in its portfolio including enterprises involved in alternative energy, carbon reduction or replacement and alt-proteins sectors. In 2020, the firm joined investment rounds for US deep-tech aerospace startup InterCosmos in July and the $84m Series A for fusion energy tech Commonwealth Fusion in May.
Founded in 2017, Starlight Ventures is a venture capital firm based in Miami, Florida. Investing mainly in US-based startups, the VC currently has 29 startups in its portfolio including enterprises involved in alternative energy, carbon reduction or replacement and alt-proteins sectors. In 2020, the firm joined investment rounds for US deep-tech aerospace startup InterCosmos in July and the $84m Series A for fusion energy tech Commonwealth Fusion in May.
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
New Food Invest: Building a plant-based business in the US
With plant-based startups experiencing exponential growth but facing increasingly intense competition, experts consider the opportunities and barriers in the sector
OLIO: Zero food waste app expands with new product categories, going global
Recent $43m Series B funding will let sustainability app more than triple hiring, add homemade products and household goods to product listings
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
Future Food Asia: Temasek, Continental Grain on investing in agrifood in Singapore and China
The two heavyweight investors discuss opportunities, needs and how agrifood startups can scale in Asian markets
Bayer Growth Ventures' Paimun Amini: Invest in tech for smarter, more sustainable farming
Corporate venture capital showed up in abundance at Smart Agrifood Malaga, where CompassList spoke with Paimun Amini, Director of Venture Investments for Bayer Growth Ventures (BGV)
Future Food Asia 2021: Impact assessments – getting the metrics right
Common impact measures are useful but each situation requires specific, sometimes subjective considerations. The priority is to gauge if the impact has led to positive changes
Future Food Asia 2021: Regenerative agriculture in Asia
The unique challenges facing regenerative agriculture in Asia require solutions different from those in the West, presenting opportunities for microfinancing and impact investment
Shilling Capital Partners: Growing Portuguese tech businesses from seed
An early mover, the influential angel investing firm is accelerating local techs into Brazil and globally
AquaCultured Foods: World's first whole-cut vegan seafood made through microbial fermentation
Armed with its fermentation technology and proprietary strain of fungi, AquaCultured is closing an oversubscribed funding round, raising more than $1.5m to launch its non-GMO seafood alternatives, with plans to expand to more food verticals and overseas
SWITCH Singapore: Race in agrifood tech as a solution to feeding 10bn people
While the potential gains are huge, giving tech solutions to farmers, especially smallholders in developing countries, remains a work in progress
Les Nouveaux Affineurs: Disrupting centuries-old French cheese culture
Backed by Michelin-star chefs and investors, Les Noveaux Affineurs is gearing up to be a global player in the billion-dollar vegan cheese market
Sorry, we couldn’t find any matches for “New Food Invest”.
